InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Woodrow Adam, Chief Executive Officer. Officer active across 1 company, notably Paratek Pharmaceuticals, Inc.. Aggregated, 15 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €73k. Activity tracked since 27 May 2021. The latest transaction was disclosed on 8 August 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations15 total
622,284 sharesCommon StockSEC:0000899243-23-019354:0
98,750 shares0Common StockSEC:0000904454-23-000480:0
22,500 shares0Common StockSEC:0000904454-22-000655:0
3,820 shares@ US$1.989.8% of flowCommon StockSEC:0000904454-22-000629:0
4,563 shares@ US$3.4721.7% of flowCommon StockSEC:0000904454-22-000534:0
15,000 shares0Common StockSEC:0000904454-22-000512:0
71,591 shares0Common StockSEC:0000904454-22-000431:0
101,250 shares0Common StockSEC:0000904454-22-000270:0
6,422 shares@ US$4.4250.0% of flowCommon StockSEC:0000904454-21-000838:0
6,422 shares@ US$4.4234.3% of flowCommon StockSEC:0000904454-21-000838
37,500 shares0Common StockSEC:0000904454-21-000622
37,500 shares0Common StockSEC:0000904454-21-000622:0
42,955 shares0Common StockSEC:0000904454-21-000520:0
42,955 shares0Common StockSEC:0000904454-21-000520
25,000 sharesCommon StockSEC:0000904454-16-000918:0
15 of 15 declarations
About Woodrow Adam
Adam Woodrow is the President and Chief Commercial Officer of Paratek Pharmaceuticals, Inc. He is responsible for the strategic and operational leadership of the company. His leadership is essential in guiding Paratek towards innovation and efficiency.
